Anticoagulation in the cirrhotic patient
Open Access
- 1 September 2019
- journal article
- review article
- Published by Elsevier in JHEP Reports
- Vol. 1 (3) , 227-239
Abstract
No abstract availableKeywords
This publication has 111 references indexed in Scilit:
- Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein ThrombosisClinical Gastroenterology and Hepatology, 2012
- Antithrombotic Therapy for VTE DiseaseChest, 2012
- The Coagulopathy of Chronic Liver DiseaseNew England Journal of Medicine, 2011
- Deep Vein Thrombosis and Pulmonary Embolism in Hospitalized Patients with Cirrhosis: A Nationwide AnalysisDigestive Diseases and Sciences, 2011
- The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patientsThrombosis Journal, 2011
- Low‐molecular‐weight heparin in patients with advanced cirrhosisLiver International, 2010
- Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver CirrhosisJournal of Clinical Gastroenterology, 2010
- Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosisJournal of Hepatology, 2004
- Natural anticoagulants and the liverJournal of Gastroenterology and Hepatology, 1997
- PREDICTIVE VALUE OF VON WILLEBRAND FACTOR TO RISTOCETIN COFACTOR RATIO AND THROMBIN-ANTITHROMBIN COMPLEX LEVELS FOR HEPATIC VESSEL THROMBOSIS AND GRAFT REJECTION AFTER LIVER TRANSPLANTATIONTransplantation, 1994